Arlington Financial Advisors, LLC Eli Lilly & CO Transaction History
Arlington Financial Advisors, LLC
- $427 Million
- Q4 2024
A detailed history of Arlington Financial Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Arlington Financial Advisors, LLC holds 508 shares of LLY stock, worth $425,201. This represents 0.09% of its overall portfolio holdings.
Number of Shares
508
Previous 433
17.32%
Holding current value
$425,201
Previous $383,000
2.35%
% of portfolio
0.09%
Previous 0.1%
Shares
3 transactions
Others Institutions Holding LLY
# of Institutions
4,289Shares Held
757MCall Options Held
10.2MPut Options Held
11.4M-
Lilly Endowment Inc Indianapolis, IN96.9MShares$81.1 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA74.2MShares$62.1 Billion1.03% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$55.1 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.3MShares$42.9 Billion26.72% of portfolio
-
State Street Corp Boston, MA34.3MShares$28.7 Billion1.07% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $795B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...